Elvira Benini

1.8k total citations
30 papers, 1.5k citations indexed

About

Elvira Benini is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Elvira Benini has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 12 papers in Cancer Research and 10 papers in Molecular Biology. Recurrent topics in Elvira Benini's work include Cancer-related Molecular Pathways (13 papers), HER2/EGFR in Cancer Research (7 papers) and Cancer Genomics and Diagnostics (5 papers). Elvira Benini is often cited by papers focused on Cancer-related Molecular Pathways (13 papers), HER2/EGFR in Cancer Research (7 papers) and Cancer Genomics and Diagnostics (5 papers). Elvira Benini collaborates with scholars based in Italy, United States and United Kingdom. Elvira Benini's co-authors include Maria Grazia Daidone, Silvia Veneroni, Rosella Silvestrini, Umberto Veronesi, G. Di Fronzo, Patrizia Boracchi, R Silvestrini, Franco Rilke, M Mezzetti and Gorana Tomasic and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Elvira Benini

30 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elvira Benini Italy 17 1.0k 741 549 204 190 30 1.5k
S M Edgerton United States 13 1.1k 1.1× 748 1.0× 661 1.2× 262 1.3× 199 1.0× 14 1.7k
Elisabeth Mueller‐Holzner Austria 18 679 0.7× 1.5k 2.0× 523 1.0× 187 0.9× 118 0.6× 31 2.1k
Pierre Rudolph Germany 25 607 0.6× 621 0.8× 335 0.6× 139 0.7× 323 1.7× 41 1.5k
Pramudita R. Prasetyanti Netherlands 13 951 0.9× 906 1.2× 504 0.9× 243 1.2× 186 1.0× 14 1.6k
Holger Dieterich Switzerland 11 793 0.8× 736 1.0× 579 1.1× 207 1.0× 178 0.9× 14 1.6k
P Bertheau France 16 800 0.8× 536 0.7× 456 0.8× 252 1.2× 234 1.2× 35 1.5k
Mark L. Levitt United States 16 1.1k 1.1× 799 1.1× 349 0.6× 202 1.0× 464 2.4× 43 1.9k
Alessandra Bersiga Italy 16 641 0.6× 458 0.6× 658 1.2× 146 0.7× 124 0.7× 31 1.2k
Paul J. van Diest Netherlands 22 549 0.5× 833 1.1× 454 0.8× 286 1.4× 184 1.0× 40 1.6k
Shannon R. Payne United States 13 797 0.8× 863 1.2× 491 0.9× 414 2.0× 366 1.9× 18 1.5k

Countries citing papers authored by Elvira Benini

Since Specialization
Citations

This map shows the geographic impact of Elvira Benini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elvira Benini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elvira Benini more than expected).

Fields of papers citing papers by Elvira Benini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elvira Benini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elvira Benini. The network helps show where Elvira Benini may publish in the future.

Co-authorship network of co-authors of Elvira Benini

This figure shows the co-authorship network connecting the top 25 collaborators of Elvira Benini. A scholar is included among the top collaborators of Elvira Benini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elvira Benini. Elvira Benini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Daidone, Maria Grazia, A Luisi, Gabriele Martelli, et al.. (2000). Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women. British Journal of Cancer. 82(2). 270–277. 32 indexed citations
2.
Daidone, Maria Grazia, Silvia Veneroni, Elvira Benini, et al.. (1999). Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancer. International Journal of Cancer. 84(6). 580–586. 46 indexed citations
3.
Daidone, Maria Grazia, A Luisi, Silvia Veneroni, Elvira Benini, & Rosella Silvestrini. (1999). Clinical studies of Bcl-2 and treatment benefit in breast cancer patients.. Endocrine Related Cancer. 6(1). 61–68. 68 indexed citations
4.
Daidone, Maria Grazia, Elvira Benini, S. Rao, Silvana Pilotti, & Rosella Silvestrini. (1998). Fixation Time and Microwave Oven Irradiation Affect Immunocytochemical p53 Detection in Formalin-Fixed Paraffin Sections. Applied Immunohistochemistry. 6(3). 140–144. 4 indexed citations
5.
Silvestrini, Rosella, Maria Grazia Daidone, Silvia Veneroni, et al.. (1998). The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol. Cancer. 82(1). 159–167. 41 indexed citations
6.
Benini, Elvira, et al.. (1998). p53 Expression in Human Carcinomas: Could Flow Cytometry Be an Alternative to Immunohistochemistry?. Journal of Histochemistry & Cytochemistry. 46(1). 41–47. 2 indexed citations
7.
Bombardieri, Emilio, Ettore Seregni, Maria Grazia Daidone, et al.. (1998). P53 Accumulation in Primary Breast Cancer: A Comparison between Immunohistochemistry and a Novel Luminometric Immunoassay. Tumor Biology. 19(1). 12–18. 5 indexed citations
8.
Daidone, Maria Grazia, Umberto Ricardi, Silvia Veneroni, et al.. (1997). Biological predictors of response to radiotherapy in cervical carcinomas. International Journal of Oncology. 10(1). 41–6. 3 indexed citations
9.
Silvestrini, Rosella, Silvia Veneroni, Elvira Benini, et al.. (1997). Expression of p53, Glutathione S -Transferase- , and Bcl-2 Proteins and Benefit From Adjuvant Radiotherapy in Breast Cancer. JNCI Journal of the National Cancer Institute. 89(9). 639–645. 88 indexed citations
10.
Daidone, Maria Grazia, Elvira Benini, Barbara Valentinis, et al.. (1996). p53 expression, DNA content and cell proliferation in primary and synchronous metastatic lesions from ovarian surface epithelial-stromal tumours. European Journal of Cancer. 32(8). 1388–1393. 9 indexed citations
11.
DiMartino, Lisa, et al.. (1996). P53, Bcl-2 expression and cell proliferation in benign breast lesions. International Journal of Oncology. 8(6). 1053–1057. 2 indexed citations
12.
Silvestrini, Rosella, Elvira Benini, Silvia Veneroni, et al.. (1996). p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients.. Journal of Clinical Oncology. 14(5). 1604–1610. 134 indexed citations
13.
Zaffaroni, Nadia, et al.. (1995). Lack of a correlation between p53 protein expression and radiation response in human tumor primary cultures. Stem Cells. 13(1). 77–85. 20 indexed citations
14.
Daidone, Maria Grazia, Rosella Silvestrini, A Luisi, et al.. (1995). Changes in biological markers after primary chemotherapy for breast cancers. International Journal of Cancer. 61(3). 301–305. 39 indexed citations
15.
Benini, Elvira, et al.. (1995). Detection of P53 expression and S-phase cell fraction in paraffin-embedded tissue by a double-labeling technique.. Journal of Histochemistry & Cytochemistry. 43(10). 999–1003. 2 indexed citations
16.
Silvestrini, R, Silvia Veneroni, Maria Grazia Daidone, et al.. (1994). The Bcl-2 Protein: a Prognostic Indicator Strongly Related to p53 Protein in Lymph Node-Negative Breast Cancer Patients. JNCI Journal of the National Cancer Institute. 86(7). 499–504. 411 indexed citations
17.
Veneroni, Silvia, Nadia Zaffaroni, Maria Grazia Daidone, et al.. (1994). Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers. European Journal of Cancer. 30(7). 1002–1007. 66 indexed citations
18.
Silvestrini, Rosella, Elvira Benini, Maria Grazia Daidone, et al.. (1993). p53 as an Independent Prognostic Marker in Lymph Node-Negative Breast Cancer Patients. JNCI Journal of the National Cancer Institute. 85(12). 965–970. 210 indexed citations
19.
Cappelletti, Vera, Danila Coradini, Eugenio Scanziani, et al.. (1992). Prognostic relevance of pS2 status in association with steroid receptor status and proliferative activity in node-negative breast cancer. European Journal of Cancer. 28(8-9). 1315–1318. 24 indexed citations
20.
Daidone, Maria Grazia, R Silvestrini, Antonia D’Errico, et al.. (1991). Laminin receptors, collagenase IV and prognosis in node‐negative breast cancers. International Journal of Cancer. 48(4). 529–532. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S M Edgerton Breakdown of academic impact, for papers by Elisabeth Mueller‐Holzner Breakdown of academic impact, for papers by Pierre Rudolph Breakdown of academic impact, for papers by Pramudita R. Prasetyanti Breakdown of academic impact, for papers by Holger Dieterich Breakdown of academic impact, for papers by P Bertheau Breakdown of academic impact, for papers by Mark L. Levitt Breakdown of academic impact, for papers by Alessandra Bersiga Breakdown of academic impact, for papers by Paul J. van Diest Breakdown of academic impact, for papers by Shannon R. Payne
Rankless by CCL
2026